Study Design. Retrospective, case-control. Objective. Evaluate the utility of preoperative autologous blood donation (PABD) for surgical treatment of adolescent idiopathic scoliosis (AIS).
Preoperative autologous blood donation (PABD) is an established method to decrease allogenic blood transfusion for patients undergoing major elective surgery. [1] [2] [3] [4] [5] The advantages of PABD include risk reduction in virus transmission and antibody formation compared with allogenic blood transfusion. 6 Studies have demonstrated willingness of participation and reduction in allogenic blood use among patients undergoing surgical treatment for adolescent idiopathic scoliosis (AIS) that use PABD. [7] [8] [9] [10] [11] [12] Consequently, PABD is a major blood conservation strategy used for adolescent spinal deformity surgery.
A growing body of literature has recently challenged the use of PABD in elective surgery. [13] [14] [15] [16] [17] Criticisms of PABD include blood overcollection, leading to reduced preoperative hematocrit levels and waste of autologous units, high cost of preparation and storage, and lower threshold for transfusing autologous blood causing unnecessary transfusions. Recent studies have reported that the most important predictor for blood transfusion following elective orthopaedic surgery is PABD. 17, 18 We preformed a retrospective analysis of autologous and allogenic blood use among patients undergoing surgery for AIS that participated in PABD and patients that did not participate in PABD (NPABD). We hypothesized that when compared with NPABD, patients participating in PABD would: 1) have a lower preoperative hematocrit, 2) be transfused at a higher hematocrit, and 3) have a greater transfusion rate.
Materials and Methods
After obtaining Institutional Review Board approval, the charts of all patients receiving surgery for AIS between January 1999 and December 2004 at 1 institution (Shriners Hopital for Children, St. Louis, MO) by the senior authors were reviewed for age, diagnosis, major curve size and location, levels fused, operative procedure, number of autologous units donated, preoperative and perioperative hematocrits drawn during hospital stay, hematocrit at transfusion, amount of autologous and allogenic blood units transfused, and amount of autologous blood discarded. All patients included in the study received primary, single-stage, posterior, anterior or combined anteroposterior instrumentation and fusion for AIS. Exclusion criteria included: 1) scoliosis etiology other than idiopathic (neuromuscular, congenital, etc.), 2) idiopathic scoliosis other than adolescent (infantile, juvenile, or adult), 3) revision surgery, and 4) staged surgery performed on more than 1 day. Patients were divided into PABD and NPABD. The PABD group was divided into number of units donated.
Statistical Analysis. Statistical analysis was performed at the Washington University Medical Center Division of Biostatistics using SAS software (SAS version 9.1, Cary, NC). Group comparisons of continuous variables were preformed using analysis of variance (ANOVA) except for variables that did not meet required conditions, in which case the Kruskal-Wallis test was used as a nonparametric alternative. When the overall ANOVA model was significant, Tukey's Studentized Range (HSD) test was used to determine the pair-wise comparisons of means that were significantly different (P Յ 0.05).
2 tests were used for between group comparisons of categorical variables. Fisher's exact test was used when categorical sample sizes were small.
Univariate odds ratios (OR) and corresponding 95% confidence intervals (CI) were computed using logistic regression. Variables that were statistically significant (P Յ 0.05) in univariate logistic regression analysis were candidates for inclusion in a stepwise, multivariate logistic regression analysis. The stepwise regression selected variables for inclusion or exclusion from the model in a sequential fashion based on the significance level of 0.1 for entry and 0.15 for removal. Adjusted odds rations and corresponding 95% CI are reported for variables included in the multivariate model, and adjusted for all variables in the model. The degree to which the adjusted logistic regression model fit the data was evaluated using goodnessof-fit statistics.
Between-group analysis comparing variables for PABD and NPABD patients was performed using unpaired t tests or 2 tests. Additional analysis was conducted in the subgroup of PABD patients to determine the association between variables and the number of PABD units not used. Unpaired t tests were used for categorical variables. Pearson correlations were used for continuous variables. Variables that were statistically significant (P Յ 0.05) were candidates for inclusion in a stepwise, multivariate linear regression analysis predicting the amount of wasted blood.
Results

Demographics
A total of 123 consecutive patients, 104 PABD and 19 NPABD, that satisfied the inclusion criteria were identified ( Table 1 ). Reasons that patients did not participate in PABD included surgery scheduling within a time frame that precluded PABD (17 patients) and patients originating from an outside country (2 patients). Seven NPABD patients had directed units available. The transfusion patterns of these 7 patients resembled those of the NPABD patients; therefore, the 7 patients with directed blood were collapsed into the 12 patients with no autologous or directed blood donated before surgery, forming 19 NPABD patients.
PABD and NPABD groups were similar for gender, age, weight, major curve Cobb angle, number of levels fused, posterior spinal fusions (PSF), anterior spinal fusions (ASF), combined anteroposterior spinal fusions (APSF), estimated blood loss, and percent of estimated blood volume loss. The preoperative hematocrit was significantly lower among PABD patients (37.8 Ϯ 3.4) compared with NPABD patients (40.2 Ϯ 2.6; P Ͻ 0.005). Thirty-five PABD patients donated 1 unit (34%), 23 donated 2 units (22%), 22 donated 3 units (21%), 21 donated 4 units (20%), and 3 donated 5 units (3%), comprising 246 total autologous units donated for an average of 2.37 Ϯ 1.22 units donated per patient. The average volume per autologous unit donated was 224.5 mL (range, 40 -440 mL). The average preoperative hematocrit declined approximately 1% for each autologous unit donated ( Figure 1 ). The correlation between the amount of PABD and the decline in preoperative hematocrit approached statistical significance (P ϭ 0.06).
Eighty patients (65%) received PSF, 37 patients (30%) received ASF, and 6 patients received APSF (5%). The average number of units donated per patient for PSF, ASF, and APSF was 2.3, 1.2, and 2.5 units, respectively (P Ͻ 0.005; ASF compared with PSF and APSF). The average blood loss for PSF, ASF, and APSF was 1011.9, 574.3, and 1116.7 mL, respectively (P Ͻ 0.005; ASF compared with PSF and APSF). The average total number of units transfused for PSF, ASF, and APSF was 2.3, 0.86, and 2.5 units, respectively (P Ͻ 0.005; ASF compared with PSF and APSF). The average number of units wasted for PSF, ASF, and APSF was 0.44, 0.38, and 0 units, respectively (P ϭ 0.418; no difference between groups). Transfusion Patterns Ninety-five PABD patients (91%) were transfused minimum one autologous unit ( Table 2 ). Ten NPABD patients (53%) were transfused minimum 1 allogenic or 1 directed unit. The rate of transfusion was significantly higher for PABD patients (P Ͻ 0.0001). A total of 213 units were transfused in the PABD group (197 autologous units and 16 allogenic units) for an average of 2 units transfused per PABD patient. Seventeen units were transfused in the NPABD group (14 allogenic and 3 directed units) for an average of 0.89 units transfused per NPABD patient. The average number of units transfused per patient was significantly higher in the PABD group (P ϭ 0.0011). Nine PABD patients (9%) were transfused allogenic blood and 8 NPABD patients (42%) were transfused allogenic blood. The discrepancy between 10 total NPABD patients transfused and only 8 NPABD patients receiving allogenic blood occurred in that 2 additional NPABD patients received directed blood only, comprising 10 total NPABD patients transfused minimum 1 unit of allogenic or directed blood. Seven NPABD patients that did not have directed blood available (54%) were transfused allogenic blood. Three NPABD patients that had directed blood available (50%) were transfused minimum 1 directed unit. One NPABD patient (17%) with directed blood available was transfused allogenic blood. PABD patients received significantly less allogenic blood than NPABD patients with or without directed blood (P Ͻ 0.0001).
The hematocrit at first transfusion was significantly higher in the PABD group compared with NPABD (28 vs. 23.7, respectively; P ϭ 0.0025). The average hematocrit at any transfusion was significantly higher in the PABD group compared with NPABD (27.8 vs. 23.9, respectively; P ϭ 0.0013). The hematocrit at allogenic blood transfusion was similar between both groups (PABD ϭ 22.7, NPABD ϭ 23.8; P ϭ 0.46).
Parameters Predictive of Transfusion
Gender, age, weight, major curve Cobb angle, curve pattern, estimated blood loss, anterior, posterior or anteroposterior procedure, and performance of thoracoplasty were not predictive of transfusion (Table 3) . Participation in PABD, number of autologous units donated, preoperative hematocrit, and number of levels fused were predictive of transfusion. The risk of transfusion increased ninefold for patients participating in PABD. Patients were approximately 3 times more likely to be transfused for each autologous unit donated. There was a 25% transfusion risk reduction for each percent increase in preoperative hematocrit. The risk for transfusion increased by 1.5 for each spine level fused. Multivariate logistic regression demonstrated that the number of levels fused was most predictive for transfusion, followed by preoperative hematocrit and number of autologous units donated.
Wasted Autologous Blood
Forty-nine (20%) autologous units were not transfused and were discarded, for an average of 0.47 units discarded per patient participating in PABD (Table 4 ). Minimum 1 autologous unit was discarded in 32 (31%) patients. One autologous unit was discarded in 19 patients, Twenty-nine PABD patients (28%) were transfused at a hematocrit Ͼ30, and 39 PABD patients (38%) were transfused at a hematocrit Ͼ28. One NPABD patient (5%) was transfused at a hematocrit Ͼ30. No other NPABD patients were transfused at a hematocrit Ͼ25. If wasted autologous units are qualified as discarded units or units transfused at an unacceptably high hematocrit (Ͼ30), minimum one autologous unit was wasted in 53 PABD patients (51%). The prediction equation for number of units wasted ϭ Ϫ2.31 ϩ 0.07 (intraoperative hematocrit) ϩ0.31 (number of units donated).
Discussion
A plethora of literature exists documenting a reduction in allogenic blood transfusion among patients participating in PABD for elective surgery. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] One problem with these reports is that they are founded on the premise that the patients transfused autologous blood would have been transfused allogenic blood had autologous blood not been available. New literature critically evaluating the use of PABD for elective surgery has raised a number of concerns with PABD, including high cost, increased transfusion rates, and wasted resources. [13] [14] [15] [16] [17] 19 Consistent with these reports, we found lower preoperative hematocrits, increased transfusion rates, and discrepant transfusion criteria for patients surgically treated for AIS that participated in PABD.
Cowell and Swickard first reported on the use of PABD in elective pediatric orthopedic surgery, noting successful autotransfusion in 147 patients. 1 A number of reports have subsequently noted the value of PABD in surgery for AIS. [7] [8] [9] 11, 12 Although these studies document a reduction in allogenic blood when using PABD, the PABD and NPABD groups are often heterogeneous and the studies often fail to report the hematocrit at transfusion, and the transfusion rates. Murray et al reported a 90% success rate in avoidance of allogenic blood transfusion among pediatric patients undergoing spine surgery that participated in PABD. 7 Hematocrit measures immediately before autologous transfusion (22.9) and allogenic transfusion (23.4) were similar. However, the PABD and NPABD groups had a mixed etiology of scoliosis. Eighty-eight percent of the PABD group had AIS, whereas 70% of the NPABD group had a neuromuscular etiology of scoliosis confounding the transfusion rate data between the study groups, as neuromuscular disease has been demonstrated to increase the need for allogenic blood. 18 More levels were fused in the NPABD group, further confounding the comparison between the PABD and NPABD groups. Almost one third of autogenic blood was discarded in this study, as 3.7 autogenic units were collected per patient, and 69% of the autologous units were transfused. Moran et al reported a 6.2% allogenic transfusion rate for AIS patients that participated in PABD, compared with a 60% allogenic transfusion rate among historical controls. 8 Indications for transfusion included hematocrit Ͻ26 in the "context of the patient's general clinical condition." Only 17% of the patients with AIS that participated in PABD received a transfusion, compared with a 60% transfusion rate for historical controls. This discrepancy in transfusion rates highlights the problem with using historical controls as a reference group. Anand et al reported the value of a standardized blood conservation protocol that included collection of 2 PABD units per patient in 50 consecutive patients receiving surgery for AIS. 11 No patient required perioperative allogenic blood. The hematocrit at transfusion, amount of autologous blood transfused, amount of autologous blood wasted, and transfusion rates were not reported. Ridgeway et al reported a 7.4% risk in allogenic transfusion in 27 patients participating in PABD compared with an 88.9% risk of allogenic transfusion in 18 NPABD patients. 12 The PABD and NPABD groups were similar for number of vertebral segments fused. Eighty-five percent of the PABD patients had AIS and no PABD patient had a neuromuscular etiology of scoliosis, whereas 61% of NPABD patients had a "neurogenic scoliosis," spina bifida, or neurofibromatosis. The perioperative hematocrit levels and specific criteria for transfusion were not reported.
Factors causing PABD waste include overcollection and discrepant transfusion criteria for autologous and allogenic blood. Letts et al reported a 53.8% accuracy rate among surgeons that attempted to predict the number of autologous units required for specific pediatric orthopedic procedures (primarily spinal fusion). 10 Billote et al, using a prospective, randomized model in which patients were randomized to 2 units of PABD or NPABD for primary total hip replacement surgery and standardized transfusion guidelines, found reduced preoperative hemoglobin values in the PABD group, increased transfusion rates in the PABD group, no reduction in allogenic blood use in the PABD group, and 41% of autologous units were wasted. 17 In a retrospective study of pediatric patients that underwent posterior spinal fusion for scoliosis, Meert et al reported the only variable that independently predicted the administration of autologous red blood cells after surgery for AIS was the amount of autologous blood donated. 18 These studies highlight the problem with protocols that mandate a number of PABD units for a given procedure. Cohen and Brecher addressed this problem by developing a mathematical model to predict the need for PABD in individual patients.
14 Their model demonstrated that PABD is often an unnecessary expense and might adversely affect patients by increasing the risk of ischemia and unnecessary transfusion due to preoperative phlebotomy. Pierson et al also developed a blood conservation algorithm to reduce blood transfusion after total hip and total knee arthroplasty. 19 Numerous studies have demonstrated a more liberal transfusion policy for autologous donors, despite findings that severe transfusion reactions are 12 times more likely in autologous donors. 13,20 -24 This practice is strongly discouraged by the Transfusion Medicine Advisory Committee because of resource waste and unnecessarily increased risk of transfusion reaction. 13,20 -24 The avoidance of transfusion, rather than avoidance of allogenic transfusion, should therefore be the goal of surgical blood conservation programs.
A number of drugs have recently been described that reduce perioperative blood loss and transfusion rates in pediatric spinal surgery. The use of antifibrinolytics such as aprotinin and Amicar (aminocaproic acid; WyethAyerst) has been well described in 3 separate prospective, randomized studies demonstrating reduced perioperative blood loss and reduced transfusion rates among patients receiving surgical treatment for AIS compared with controls. [25] [26] [27] Recombinant human erythropoietin (rh-EPO) has also been shown to reduce the risk of transfusion in pediatric patients undergoing spine surgery. 28 These drugs have tremendous potential; however, their use has not been universally adopted. PABD is a more widely used blood conservation technique. Consequently, treating surgeons may be more apt to alter their PABD practices based on a set of proven guidelines rather than introduce a new drug. Accurate PABD guidelines could then provide a control by which the effect other interventions have on perioperative blood management.
Limitations of the current study include the retrospective design and inclusion of directed donors within the NPABD study group. Although the demographics and operative data for patients in the PABD and NPABD groups were similar, we cannot exclude a possible difference between the 2 groups explaining the differences in transfusion practices. We acknowledge that a retrospective study cannot supplant a prospective, randomized study. Therefore, we are currently initiating a prospective randomized study evaluating the efficacy of PABD for patients undergoing surgery for AIS. We hope that the prospective study will overcome the limitations of this study and provide PABD guidelines for surgeons that treat AIS. Collapsing the directed donors into the NPABD group may have also introduced error into the NAPBD group despite statistical analysis that demonstrated similar transfusion practices between NPABD patients that did and did not have directed blood available. We anticipate that the prospective arm of this study will eliminate heterogeneity within the study groups without compromising statistical power.
Conclusion
We demonstrated decreased preoperative hematocrit and increased transfusion rates among patients participating in PABD. PABD patients were transfused at a higher hematocrit than NPABD patients. The hematocrit at allogenic blood transfusion was similar between PABD and NPABD groups. Minimum one autologous unit was discarded or a transfusion occurred at an unacceptably high hematocrit in the majority of patients (51%) participating in PABD.
Key Points
• PABD lowers preoperative hematocrit and increases the risk for transfusion after surgery for AIS.
• Different transfusion criteria are applied to PABD and NPABD patients undergoing surgery for AIS.
• Excessive PABD is a source of wasted resources for patients undergoing surgery for AIS.
• More precise PABD guidelines are needed for AIS surgery to limit unnecessary transfusion and wasted resources.
